Cohort | Mean age ± SD (years) | Male sex (%) | Viral hepatitis (%) | Liver cirrhosis (%) | CTP class (%) | BCLC stage (%) | OS (months) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | B | C | 0 | A | B | C | D | Â | |||||
US training [17] n = 310 | 62.6 ± 11.8 | 70.3 | 44.8 | 62.6 | 71.2 | 25.5 | 2.6 | 6.5 | 8.7 | 9.7 | 63.2 | 7.4 | 13.2 |
US validation [17] n = 155 | 63.2 ± 10.8 | 72.9 | 50.3 | 63.6 | 81.3 | 16.1 | 2.6 | 1.3 | 8.4 | 11.0 | 76.8 | 2.5 | 15.7 |
Egyptian [26] n = 100 | 56.7 ± 8.7 | 83.0 | 100.0 | 87.0 | 40.0 | 32.0 | 28.0 | 0.0 | 1.0 | 8.0 | 60.0 | 31.0 | 8.6 |
Korean [27] n = 393 | 56.8 ± 9.5 | 77.9 | 91.1 | 48.9 | 85.0 | 14.5 | 0.5 | 20.9 | 40.2 | 9.4 | 29.0 | 0.5 | Missing |
German n = 216 | 67.6 ± 9.5 | 86.1 | 14.6 | 81.3 | 50.0 | 32.4 | 17.6 | 0.0 | 16.7 | 11.6 | 51.4 | 20.4 | 11.4 |